Summary of Purpose
This is a long-term safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper limb spasticity. Trial Stopped: The study was withdrawn prior to enrollment due to corporate decision.Read More →
The following dates are available for this trial. Trial information last updated on 12 August 2014.
|1 Aug 2014||21 May 2014||1 May 2017||1 May 2017||1 Aug 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allergan Lead
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Allergan Inc.